Tim Little, a 60-year-old former electrician from Witham, Essex, has described a stark contrast between his experiences receiving medical care for dementia and for a suspected cancerous condition. His account highlights ongoing concerns about the prioritization and support for dementia patients in the healthcare system.

Mr. Little first sought medical advice in 2019 after noticing difficulties completing routine tasks, such as electrical wiring at work. Having previously undergone treatment for a benign brain tumor, he initially feared his symptoms might be related to that condition. However, after a protracted diagnostic process spanning nearly 18 months—including a six-month wait for a memory clinic appointment followed by a year of tests and consultations—he was diagnosed with Lewy body dementia in late 2020. This form of dementia, which accounts for 10 to 15 percent of cases, is characterized by the buildup of abnormal protein clumps called alpha-synuclein that interfere with brain function, causing symptoms such as slow movement, tremors, visual hallucinations, and acting out nightmares.

Mr. Little learned of his diagnosis during the COVID-19 lockdown through a phone call from his consultant, who advised him to update his will and arrange power of attorney. Left to process the information on his own over the weekend, Mr. Little turned to online resources that estimated he had around five years to live, leading to severe depression and anxiety. He has also struggled with medication side effects, including increased tremors, paranoia, and heightened anxiety. Some of his daily challenges include leaving the gas on inadvertently or incompletely cleaning his home.

A year after his dementia diagnosis, Mr. Little returned to his general practitioner complaining of a mild, persistent cough. Within a week, he underwent a CT chest scan and blood tests to rule out lung disease or cancer, all of which returned clear. This swift diagnostic approach, followed by immediate treatment with antibiotics that resolved the infection, underscored for him the significant difference in responsiveness compared to his experience with dementia care.

Expressing frustration with the lack of urgency and support for dementia patients, Mr. Little said, “We need dementia to be prioritised in the way that cancer has been.” He added that dementia remains “a dirty word,” reflecting the stigma that continues to surround the condition.

In response to his diagnosis and the challenges he has faced, Mr. Little has become an advocate for others with dementia. He has helped establish a local support group and regularly speaks at conferences and events organized by dementia charities, sharing his journey and emphasizing the need for improved care and understanding.

Despite these efforts, Mr. Little candidly noted the lasting impact of his diagnosis, stating, “The truth is, I wish I’d got cancer instead. At least it is potentially treatable—dementia isn’t.”